Psykey, Inc. (CEOS)

0.0600 -0.0040 (-6.25%) At close: 03:53PM EDT

Psykey, Inc.

17 Belfield Road
Etobicoke
Toronto, ON M9W1E8
Canada
888 376 8258
https://www.psykeyworld.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 6

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. James J. Fiedler	Chairman & CEO	N/A	N/A	1947
Mr. Robert Gardiner	Pres & Director	N/A	N/A	N/A
Sukhinder Kalsi	CFO & Director	N/A	N/A	N/A
Mr. Mark Perkell	VP and Gen. Counsel	N/A	N/A	N/A
Dr. Allen Greenspoon M.D.	VP & Director	N/A	N/A	1954
Dr. Jasbir S. Kang M.D.	Treasurer, Sec. & Director	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Corporate Governance

Psykey, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.